Literature DB >> 25823811

Rodent models for human diseases.

Thierry F Vandamme1.   

Abstract

One of the factors limiting the translation of knowledge from preclinical studies to the clinic has been the limitations of in vivo diseases models. Except in the case of highly controlled and regulated clinical trials, geneticists and scientists do not use humans for their experimental investigations because of the obvious risk to life. Instead, they use various animal, fungal, bacterial, and plant species as model organisms for their studies. Amongst these model organisms, rodent models are the most used due to the easiness for the experiments and the possibility to modify genetically these model animals. Nevertheless, due to the fact that animal models typically do not contract the same genetic diseases as people, so scientists must alter their genomes to induce human disease states and to know what kind of mutation causes the disease. In this brief review, we will discuss the interests of rodent models that have been developed to simulate human pathologies, focusing in models that employ xenografts and genetic modification. Within the framework of genetically engineered mouse (GEM) models, we will review some of the current genetic strategies for modeling diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Diseases; Genetically engineered model animals; Rodent; Xenografts model animals

Mesh:

Year:  2015        PMID: 25823811     DOI: 10.1016/j.ejphar.2015.03.046

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Development of Humanized Mice in the Age of Genome Editing.

Authors:  Vishnu Hosur; Benjamin E Low; Cindy Avery; Leonard D Shultz; Michael V Wiles
Journal:  J Cell Biochem       Date:  2017-05-15       Impact factor: 4.429

Review 2.  Comparing human and mouse salivary glands: A practice guide for salivary researchers.

Authors:  C L Maruyama; M M Monroe; J P Hunt; L Buchmann; O J Baker
Journal:  Oral Dis       Date:  2018-04-24       Impact factor: 3.511

3.  Generation of insulin-deficient piglets by disrupting INS gene using CRISPR/Cas9 system.

Authors:  Bumrae Cho; Su Jin Kim; Eun-Jin Lee; Sun Mi Ahn; Jin Seok Lee; Dal-Young Ji; Kiho Lee; Jung-Taek Kang
Journal:  Transgenic Res       Date:  2018-04-24       Impact factor: 2.788

4.  Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Authors:  Hui-Fang Liu; Philip Wing-Lok Ho; Gideon Chi-Ting Leung; Colin Siu-Chi Lam; Shirley Yin-Yu Pang; Lingfei Li; Michelle Hiu-Wai Kung; David Boyer Ramsden; Shu-Leong Ho
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

Review 5.  Three-dimensional bio-printing: A new frontier in oncology research.

Authors:  Nitin Charbe; Paul A McCarron; Murtaza M Tambuwala
Journal:  World J Clin Oncol       Date:  2017-02-10

6.  Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model.

Authors:  Pierre-Simon Bellaye; Alexandra Oudot; Jean-Marc Vrigneaud; Olivier Raguin; Francis Bichat; Anne Vaslin; Hélène Maby-El Hajjami; Claudio Zanna; Grégoire Vuagniaux; Pierre Fumoleau; Franck Denat; François Brunotte; Bertrand Collin
Journal:  Contrast Media Mol Imaging       Date:  2018-12-02       Impact factor: 3.161

7.  Animal models of human atherosclerosis: current progress.

Authors:  A V Poznyak; Y Y Silaeva; A N Orekhov; A V Deykin
Journal:  Braz J Med Biol Res       Date:  2020-05-18       Impact factor: 2.590

8.  Dysbiosis of gut microbiome affecting small intestine morphology and immune balance: a rhesus macaque model.

Authors:  Hong-Zhe Li; Nan Li; Jing-Jing Wang; Heng Li; Xing Huang; Lei Guo; Hui-Wen Zheng; Zhan-Long He; Yuan Zhao; Ze-Ning Yang; Hai-Tao Fan; Man-Man Chu; Jin-Xi Yang; Qiong-Wen Wu; Long-Ding Liu
Journal:  Zool Res       Date:  2020-01-18

Review 9.  INFRAFRONTIER: a European resource for studying the functional basis of human disease.

Authors:  Michael Raess; Ana Ambrosio de Castro; Valérie Gailus-Durner; Sabine Fessele; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2016-06-04       Impact factor: 2.957

10.  Dominant negative Gfi1b mutations cause moderate thrombocytopenia and an impaired stress thrombopoiesis associated with mild erythropoietic abnormalities in mice.

Authors:  Hugues Beauchemin; Peiman Shooshtharizadeh; Jordan Pinder; Graham Dellaire; Tarik Möröy
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.